Related Experiment Video

Updated: May 8, 2026

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
12:22

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput

Published on: September 22, 2019

Identification of MFG-E8 as a novel therapeutic target for diseases

Bao-Zhu Li1, Hai-Yan Zhang, Hai-Feng Pan

  • 1Anhui Medical University, School of Public Health, Department of Epidemiology and Biostatistics , 81 Meishan Road, Hefei, Anhui, 230032 , PR China +86 551 5167726 ; +86 551 5161171 ; ydq@ahmu.edu.cn.

Expert Opinion on Therapeutic Targets
|August 27, 2013
PubMed
Abstract

Insights

Milk fat globule-epidermal growth factor-factor 8 (MFG-E8) is a glycoprotein with diverse functions. Emerging research highlights its potential as a therapeutic target for various diseases, including inflammatory and age-related conditions.

Area of Science:

  • Biochemistry
  • Immunology
  • Molecular Biology

Background:

  • Milk fat globule-epidermal growth factor-factor 8 (MFG-E8) is a glycoprotein with widespread expression and diverse functions.
  • Traditionally recognized for its role in apoptotic cell clearance and immune system modulation.
  • Recent research reveals novel insights into MFG-E8's involvement in various disease pathologies.

Purpose of the Study:

  • To provide a comprehensive overview of recent advancements concerning MFG-E8.
  • To explore the multifaceted roles of MFG-E8 in different disease contexts.
  • To highlight the potential therapeutic applications of MFG-E8.

Main Methods:

  • Literature review of current research on MFG-E8.
  • Analysis of MFG-E8's functions in inflammatory diseases, autoimmune conditions, aging, and cancer.
  • Synthesis of findings to assess therapeutic potential.

Main Results:

  • MFG-E8 exhibits multifunctional roles in attenuating inflammation and improving outcomes in autoimmune diseases.
  • It plays a role in wound healing, arterial remodeling, and influences tumorigenicity and cancer metastasis.
  • The glycoprotein's involvement spans age-related diseases and various cancers.

Conclusions:

  • While the precise mechanisms of MFG-E8 in disease require further elucidation, it shows significant promise.
  • MFG-E8 represents a potential therapeutic strategy for a range of conditions.
  • Further research into MFG-E8-based strategies could lead to novel treatments.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...